Should I Buy HRZN? HRZN 2026 Analysis

Should You Buy Horizon Technology Finance Corp (HRZN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

6.680

1 Day change

0.15%

52 Week Range

9.740

Analysis Updated At

2026/01/29

Buy (long-term, beginner-friendly entry). HRZN is trading near a key pivot/support area (~6.66 with S1 ~6.58), technicals are neutral-to-slightly constructive, options positioning is call-leaning (put/call ratios < 1), and the latest reported quarter (2025/Q3) shows very strong YoY growth in revenue, earnings, and EPS. With no near-term negative news catalysts and no insider/hedge fund selling pressure flagged, it’s a reasonable buy now for an investor who doesn’t want to wait for a perfect entry.

Technical Analysis

Price/Trend: HRZN is essentially sideways around the pivot (Pivot 6.668) after a small down day (-0.30%). Momentum: MACD histogram is slightly positive (0.000611) but contracting, consistent with a range-bound market rather than a strong uptrend. RSI(6) ~52 is neutral (no overbought/oversold). Moving averages are converging, which typically signals consolidation. Key levels: Support at S1 6.576 then S2 6.519; Resistance at R1 6.759 then R2 6.816. Practical read: The chart suggests a neutral base; buying near current levels is effectively buying near support within the range, with upside if it re-tests 6.76–6.82.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Put/call ratios below 1 (OI 0.43; volume 0.5) indicate bullish-to-neutral positioning (more call interest than puts). Volatility: Implied vol (30d) ~19.42 is low vs historical vol ~39.05, with IV percentile ~9.2 and IV rank ~6.79—options are relatively cheap by recent standards and the market is not pricing in big near-term moves. Activity: Today’s volume is light (48 contracts) but open interest is call-heavy (call OI 2281 vs put OI 982). Overall: Options data leans constructive but not “high-conviction breakout” signaling.

Technical Summary

Sell

Buy

Positive Catalysts

1) Strong latest quarter growth (2025/Q3) across revenue, net income, and EPS. 2) Options positioning leans bullish (put/call ratios < 1). 3) No adverse news flow in the past week (no fresh negative catalysts). 4) Price is sitting near support/pivot, which can favor a stable long-term entry.

Neutral/Negative Catalysts

1) Technicals are not in a clear uptrend (MACD positive but weakening; moving averages converging), so upside may be gradual rather than immediate. 2) Analyst price target mentioned ($6.50) is slightly below the current price (~$6.66–$6.67), which caps near-term enthusiasm even though the rating is Buy. 3) Pattern-based forward odds provided suggest slightly negative drift over week/month (minor downside bias).

Financial Performance

Latest quarter: 2025/Q3. Revenue rose to 44,308,000 (+121.50% YoY). Net income increased to 30,722,000 (+322.12% YoY). EPS grew to 0.67 (+235.00% YoY). Gross margin improved to 98.04 (+3.12% YoY). Bottom line: Reported growth trends are strongly positive, supporting a long-term buy case.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Limited coverage in the provided data, but the latest update (2025-11-19) shows UBS (Doug Harter) maintained a Buy rating and raised the price target to $6.50 from $6.25. Wall Street pros: Buy rating and upward target revision support the stock. Cons: The $6.50 target is still below the current price, implying modest expected upside from here based on that single referenced view. Intellectia Proprietary Trading Signals: **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently. Influential/Political trading: No recent congress trading data available. Hedge funds/insiders: Neutral, no significant recent trends.

3 Analyst Rating

Wall Street analysts forecast HRZN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HRZN is 6.67 USD with a low forecast of 6 USD and a high forecast of 7.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

1 Sell

Hold

Current: 6.670

Low

Averages

6.67

High

7.5

Current: 6.670

Low

Averages

6.67

High

7.5

UBS

Doug Harter

Buy

maintain

AI Analysis

2025-11-19

Reason

UBS

Doug Harter

Price Target

AI Analysis

2025-11-19

maintain

Buy

Reason

UBS analyst Doug Harter raised the firm's price target on Horizon Technology to $6.50 from $6.25 and keeps a Buy rating on the shares.

UBS

Neutral

downgrade

2025-10-14

Reason

UBS

Price Target

2025-10-14

downgrade

Neutral

Reason

UBS lowered the firm's price target on Horizon Technology to $6.25 from $7 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HRZN

Unlock Now

HRZN Should I Buy

HRZN Should I Buy

Should You Buy Horizon Technology Finance Corp (HRZN) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch